首页> 外文期刊>Psychiatric genetics >Analysis of gastrin-releasing peptide gene and gastrin-releasing peptide receptor gene in patients with agoraphobia
【24h】

Analysis of gastrin-releasing peptide gene and gastrin-releasing peptide receptor gene in patients with agoraphobia

机译:恐惧症患者胃泌素释放肽基因和胃泌素释放肽受体基因的分析

获取原文
获取原文并翻译 | 示例
           

摘要

A gastrin-releasing peptide receptor (GRPR) knock-out mouse model provided evidence that the gastrin-releasing peptide (GRP) and its neural circuitry operate as a negative feedback-loop regulating fear, suggesting a novel candidate mechanism contributing to individual differences in fear-conditioning and associated psychiatric disorders such as agoraphobia with/without panic disorder. Studies in humans, however, provided inconclusive evidence on the association of GRP and GRPR variations in agoraphobia with/without panic disorder. Based on these findings, we investigated whether GRP and GRPR variants are associated with agoraphobia. Mental disorders were assessed via the Munich-Composite International Diagnostic Interview (M-CIDI) in 95 patients with agoraphobia with/without panic disorder and 119 controls without any mental disorders. A complete sequence analysis of GRP and GRPR was performed in all participants. We found no association of 16 GRP and 7 GRPR variants with agoraphobia with/without panic disorder. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
机译:胃泌素释放肽受体(GRPR)敲除小鼠模型提供了证据,表明胃泌素释放肽(GRP)及其神经回路可作为负反馈回路调节恐惧,这提示了导致恐惧个体差异的新型候选机制适应症和相关的精神疾病,例如患有/没有恐慌症的恐惧症。然而,人类研究提供了关于恐惧症和不伴恐慌症的GRP和GRPR变异关系的不确定性证据。基于这些发现,我们调查了GRP和GRPR变异是否与恐惧症有关。通过慕尼黑综合国际诊断访谈(M-CIDI)对95名患有/没有恐慌症的恐高症患者和119名没有任何精神障碍的对照组的精神障碍进行了评估。在所有参与者中进行了GRP和GRPR的完整序列分析。我们发现没有伴有恐慌症或没有恐慌症的恐慌症的16种GRP和7种GRPR变异。 (C)2014 Wolters Kluwer Health垂直条Lippincott Williams&Wilkins。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号